Tag: Stock pick

The S&P/ASX 200 Index (ASX: XJO) experienced a partial rebound after the Australian Bureau of Statistics (ABS) revealed steady unemployment at 4.3% today.

The seasonally adjusted unemployment rate held last month amid an 18,000 increase in the number of people employed.

The number of unemployed people fell by 4,000, while the participation rate dropped 0.1% to 66.8%.

Sean Crick, ABS head of labour statistics, said:

Growth in employment was driven by full-time workers, which rose by 53,000 people in March.

This was partly offset by a fall in part-time employment of 35,000 people.

Full-time employment increased by 29,000 for men and 24,000 for women.

Part-time employment fell by 19,000 for men and 16,000 for women.

ASX 200 rebounds then resumes downward trend

The ASX 200’s partial rebound after the jobs data was released at 11.30am was short-lived.

The local bourse has been in the red all day as the US and Iran consider an extension to their two-week ceasefire.

The market is also absorbing the news of a major fire at one of Australia’s two oil refineries today.

The ASX 200 is currently down 0.21% to 8,960.1 points.

Meanwhile, the Australian dollar has lifted to 71.9 US cents, its highest level in four years.

The increase comes as the market ascribes a 67% chance of an interest rate rise next month.

The Reserve Bank board meets on 4-5 May.

As of yesterday, the market had a 67% expectation of a rate rise, up from 62% a week ago.

Higher interest rates tend to support the AUD against the USD because they increase returns on Australian assets relative to US assets.

RBA not confident interest rates are high enough

Analysts at Trading Economics said the jobs data reinforced the Reserve Bank’s view that the labour market remains relatively tight.

The jobs market has demonstrated resilience despite business and consumer confidence tanking due to the global fuel crisis.

Earlier this week, Deputy Reserve Bank Governor, Andrew Hauser, said inflation was already rising before the Iran war, and the fuel crisis was an additional shock, adding more pressure to businesses.

Hauser said:

The rates will have to go to a level that bring inflation back to target … And if that means them going higher, it means them going higher.

I wouldn’t say we have high confidence that we’ve yet set interest rates at the right level…

Hauser said many Australian companies had found it difficult to raise their prices, and the fuel crisis may help them get increases through.

Westpac Banking Corp (ASX: WBC) Chief Economist Luci Ellis, a former RBA Assistant Governor, expects three more interest rate rises.

This would take the cash rate to 4.85%.

A tight jobs market can contribute to resurgent inflation because people are willing to spend when they feel secure in their jobs.

The post Interest rate rise expectations firm on jobs data as Aussie dollar hits 4-year high appeared first on The Motley Fool Australia.

More reading

• Court approves Insignia Financial scheme: $4.80 per share for holders
• Whitehaven Coal announces US$900m notes issue and debt refinancing
• Viva Energy share price halted pending update on Geelong Refinery fire
• AMP posts Q1 2026 results, launches $150m buyback
• Netwealth Group lifts FUA to $125.8B with strong quarterly flows

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is down 0.2% in early afternoon trade on Thursday, but that’s not keeping these three ASX 200 titans from notching new 52-week-plus highs.

One of today’s stars is a financial company, the second produces uranium, and the third is a lithium producer.

So, which companies are hitting new high-water marks?

Read on!

Macquarie Group Ltd (ASX: MQG) lifts on positive sentiment

Macquarie shares are up 1.7% at the time of writing, changing hands for $239.14 each.

That’s the highest share price for the ASX 200 diversified financial stock since January 2025. And it sees the Macquarie share price up 33% in 12 months. Macquarie shares also trade on a partly franked 2.8% trailing dividend yield.

The last price-sensitive news out from the company was its third-quarter trading update back on 10 February.

But the stock may be getting an added boost this week amid an upgrade from Morgan Stanley. The broker has an overweight weighting on Macquarie shares with a $270 price target. That represents a potential upside of almost 13% from current levels.

PLS Group Ltd (ASX: PLS) gets a funding boost

PLS Group – formerly known as Pilbara Minerals – is also hitting new highs today.

Shares in the ASX 200 lithium titan are up 3.1% at the time of writing, trading for $5.56 apiece. That’s not just a new one-year high, but if PLS can hold these gains to close, it will mark a new all-time high for the stock.

PLS looks to be getting an added boost today after announcing a new US$600 million (AU$847 million) debt funding issuance.

The new senior unsecured notes come due in 2031 at an annual interest rate of 6.88%. The lithium miner intends to use the proceeds to refinance its AU$375 million drawn-on revolving credit facility and for general operating purposes.

Paladin Energy Ltd (ASX: PDN) shares riding the uranium wave

Paladin Energy shares are also trading in new one-year-plus high territory today.

Shares in the ASX 200 uranium stock are up 4.4%, changing hands for $14.40 each. That’s the highest level since June 2024.

There’s no fresh news out from Paladin Energy, but the uranium sector is broadly outperforming today amid rising global sentiment for the nuclear fuel.

Looking at some of Paladin’s chief rivals, Boss Energy Ltd (ASX: BOE) shares are up 6.1% today, Bannerman Energy Ltd (ASX: BMN) shares are up 4.4%, and Deep Yellow Ltd (ASX: DYL) shares are up 2.3%.

The post 3 ASX 200 titans charging to new one-year-plus highs today appeared first on The Motley Fool Australia.

More reading

• Why the PLS share price just hit an all-time high
• Why is everyone talking about New Hope, PLS and Viva Energy shares on Thursday?
• Why I’d buy these ASX 200 stocks if I were a beginner
• PLS Group prices US$600m in senior notes for growth and refinancing
• Macquarie shares soar 21% to a 52-week high: Buy, sell or hold?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you have $10,000 ready to invest, putting it into high-quality ASX growth shares can be a smart way to build long-term wealth.

However, you can’t just put it in any old share. The key is focusing on businesses with scalable models, strong tailwinds, and the ability to keep growing earnings over time.

While there will always be volatility along the way, the right companies can reward patient investors.

Here are three ASX growth shares that analysts think could be worth considering.

Pro Medicus Ltd (ASX: PME)

The first ASX growth share that could be a standout pick is Pro Medicus.

It operates in medical imaging software and has built a reputation as one of the highest-quality growth companies on the ASX.

What makes it particularly compelling is its business model. The company wins large, long-term contracts with hospitals and healthcare providers, creating recurring revenue and strong visibility over future earnings.

It also operates with very high margins, which means a large portion of its revenue flows through to profit.

The team at Bell Potter thinks recent share price weakness has created a buying opportunity. Earlier this week, it put a buy rating and $226.00 price target on its shares.

Life360 Inc (ASX: 360)

Another ASX growth share that could be worth considering is Life360.

Life360 has built a global platform focused on family safety and location sharing, with almost 100 million active users.

The company is increasingly monetising its platform through subscriptions, partnerships, advertising, and new services. This is underpinning significant recurring revenue.

And with management confident that 2026 will see further strong user growth, Life360 looks likely to deliver another year of stellar revenue and profit growth.

Bell Potter is also bullish on this one and recently put a buy rating and $35.50 price target on its shares.

WiseTech Global Ltd (ASX: WTC)

A third ASX growth share that could be worth considering is WiseTech Global.

It provides software solutions for the global logistics industry, with its CargoWise platform deeply embedded in customer operations.

This creates strong switching costs and recurring revenue, both of which are attractive traits in a growth company.

The company continues to expand its product offering and global reach, positioning itself at the centre of increasingly complex supply chains.

With global trade becoming more digitised, WiseTech has a long runway for growth.

Last week, the team at Morgan Stanley put an overweight rating and $70.00 price target on its shares.

The post 3 ASX growth shares to buy with $10,000 appeared first on The Motley Fool Australia.

More reading

• Why AMP, Life360, Netwealth, and Ora Banda shares are racing higher today
• Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?
• 5 ASX ETFs that could supercharge your portfolio
• One ASX share to double, one yielding 11% — ASX picks for April
• 2 ASX 200 shares down 30%+ that I’d buy with $4,000

Motley Fool contributor James Mickleboro has positions in Life360, Pro Medicus, and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and WiseTech Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360 and WiseTech Global. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

After spending months under pressure, Netwealth Group Ltd (ASX: NWL) shares are finally drawing stronger buying interest again on Thursday.

At the time of writing, the Netwealth share price is up 5.86% to $25.215, extending its gain over the past month to roughly 17%.

The rebound comes after the stock traded above $38 at its 2025 peak before sliding through much of this year.

Today’s move suggests confidence is rebuilding in Netwealth’s ability to keep attracting adviser and client funds despite recent market volatility.

Here’s what investors are looking at today.

March quarter flows stay strong

According to the release, Netwealth reported total funds under administration (FUA) of $125.8 billion, up 20.9% on the prior corresponding period.

More notably, quarterly FUA net flows came in at $4 billion, which more than offset a $3.7 billion market movement decline during the period.

Custodial FUA net flows were $3.9 billion, up 12.5% on the prior corresponding period, while total FUA net flows excluding pension payments rose 13.6% to $4.3 billion.

The number of accounts also continued rising, increasing by 4,454 during the quarter to 176,675, which is 13.4% above the prior corresponding period.

Managed account net flows remained especially strong at $1.2 billion, up 34.8% year on year, reinforcing that advisers are still directing more client assets onto the platform.

Why this quarter landed well with investors

The market response appears tied less to the overall FUA figure and more to the strength of the underlying flows.

The March quarter was choppy, with the S&P/ASX All Ordinaries Index (ASX: XAO) falling 3.7% across the period, yet Netwealth still delivered enough net inflows to lift total FUA.

That tells us Netwealth is still winning adviser market share rather than benefiting from broader market conditions.

The update also showed platform activity stayed elevated through March. Average cash balances stayed steady at 5.7% of custodial FUA, while flows continued through existing intermediary channels.

Another encouraging detail is that higher-margin managed accounts are still expanding faster than the broader platform base.

That rapid growth should also support stronger earnings over time.

Outlook remains supportive

Management also pointed to continued progress across product initiatives, including the rollout of its individual HIN solution and broader enhancements to adviser workflow tools.

These platform upgrades can help support retention and make it easier for advisers to consolidate more client assets onto one system.

The wider industry backdrop also remains favourable.

More advisers are still moving client money away from older platforms, and Netwealth continues to capture part of that shift.

The post This beaten-down ASX financial share is bouncing back fast today appeared first on The Motley Fool Australia.

More reading

• Why AMP, Life360, Netwealth, and Ora Banda shares are racing higher today
• 3 ASX 300 shares that could be much bigger in 5 years
• Netwealth Group lifts FUA to $125.8B with strong quarterly flows
• These ASX shares look too good to ignore after the recent pullback
• 3 ASX shares that could double over the next decade (or much sooner)

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Sims Ltd (ASX: SGM) shares are edging lower today.

Shares in the S&P/ASX 200 Index (ASX: XJO) metal and electronics recycler closed yesterday trading for $20.17. During the Thursday lunch hour, shares are changing hands for $19.93 apiece, down 1.2%.

For some context, the ASX 200 is down 0.3% at this same time.

Taking a step back, Sim shares have strongly outperformed over the past year. Shares in the ASX 200 industrial stock have gained 45% in 12 months, racing ahead of the 15.4% one-year gains posted by the benchmark index.

And that doesn’t include the two fully-franked dividends the company paid eligible stockholders over this time. Sims stock trades on a fully-franked trailing dividend yield of 1.4%.

And looking to the months ahead, Shaw and Partners’ Jed Richards expects the stock is well-placed to deliver more outperformance (courtesy of The Bull).

Here’s why.

Should you buy Sims shares today?

“Sims offers exposure to long term stronger and sustainable commodity themes through its global metals recycling operations, particularly in Europe,” said Richards, citing the first reason you might want to buy Sims shares today.

As for the second reason, Richards noted, “Demand for recycled inputs, such as lithium, copper and gold, continue to grow as electrification and decarbonisation trends advance.”

Richards concluded:

The business provides leverage to improving industrial activity, although earnings can be volatile given commodity price swings and cyclical end markets.

In our view, the strategic positioning justifies a buy despite near term volatility.

The (slightly less) bullish case for the ASX 200 industrial stock

DP Wealth Advisory’s Andrew Wielandt also ran his slide rule over Sims shares on The Bull this week.

“Sims is a global metals and electronics recycler providing exposure to North America, the United Kingdom, Australia and New Zealand,” said Wielandt, who has a hold recommendation on the ASX 200 stock following the strong run higher in its share price.

According to Wielandt:

The outlook for Sims is encouraging in response to the company upgrading full year earnings guidance. Impressive share price gains in the past 12 months leaves SGM a hold for now and a potential buy on further weakness. The stock has risen from $12.51 on April 9, 2025 to trade at $20.62 on April 9, 2026.

What’s the latest on Sims shares?

As Wielandt mentioned above, on 18 March, Sims announced that it expects full-year FY 2026 underlying earnings before income on tax (EBIT) to be in the range of $350 million to $400 million.

That’s a big leg up from FY 2025 underlying EBIT of $175 million.

Sims shares closed up 9.9% on the day of the announcement.

The post Up 45% in a year, 3 reasons to buy Sims shares today appeared first on The Motley Fool Australia.

More reading

• Forget CBA shares and buy this ASX 200 stock: Shaw & Partners
• Sims Group earnings: SLS now core to growth
• Sims Group posts robust US growth through SA Recycling in FY26
• 3 ASX 200 stocks screaming higher in this week’s sinking market
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

PLS Group Ltd (ASX: PLS) shares hit an all-time high today, extending one of the ASX’s strongest large-cap runs.

At the time of writing, the PLS share price is up 4.17% to $3.615, marking a new record and taking its 12-month gain to more than 300%.

The rally builds on what has already been a huge run, with stronger lithium sentiment and institutional buying continuing to support the shares.

The latest move suggests buyers are still comfortable backing the stock even at peak levels.

Here’s what the company announced.

PLS upsizes its debt raise to US$600 million

According to the release, PLS has priced a US$600 million senior unsecured notes offering due 2031. The size is above the original US$500 million flagged earlier this week.

The notes will carry a 6.875% coupon and settle on 22 April, subject to customary conditions.

Management said that part of the proceeds will be used to refinance the company’s existing $375 million revolving credit facility and its $1 billion revolving credit facility.

The balance will be used for general corporate purposes, giving the lithium producer added flexibility as it continues expanding its battery materials footprint across Australia, Brazil, and South Korea.

At the same time as the deal closes, PLS said it plans to reduce the size of its revolving credit facility from $1 billion to $500 million.

Why investors are backing the funding strategy

PLS is making this move while its share price is at record highs and while lithium market sentiment has continued improving through 2026.

That gives management a stronger position to lock in longer-dated capital without leaning on equity markets.

The announcement also follows Fitch assigning the company a BB issuer rating with a stable outlook earlier this week. The rating likely helped support institutional demand for the notes.

The update looks less about near-term balance sheet pressure and more about strengthening funding capacity ahead of future growth options.

That can include downstream lithium chemicals, Brazilian project development, and broader strategic partnerships.

Foolish Takeaway

I still think this looks like a smart funding move from PLS while sentiment and balance sheet strength are working in its favour.

The company is locking in longer-dated capital without touching equity, which should help preserve upside if lithium conditions keep improving.

After a 300%-plus run over 12 months, I would not expect the same pace of gains from here.

Still, stronger financial flexibility and improving lithium sentiment can keep supporting the valuation at these levels.

The post Why the PLS share price just hit an all-time high appeared first on The Motley Fool Australia.

More reading

• Why is everyone talking about New Hope, PLS and Viva Energy shares on Thursday?
• PLS Group prices US$600m in senior notes for growth and refinancing
• Will these top-performing ASX stocks keep charging higher?
• This ASX lithium giant just hit a record high again. Here’s why investors keep chasing it
• Up 106% in six months, here are the latest growth forecasts for the PLS Group share price

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

After hitting levels higher than $3 in early January, shares in Mesoblast Ltd (ASX: MSB) have largely been on the slide, which is creating a buying opportunity, according to the analyst team at Canaccord Genuity.

Mesoblast actually had some good news this week, which we’ll get to later, but first, let’s look at why the Canaccord team is bullish on the stock.

Strong product pipeline

The company held a research and development day last week, which the Canaccord team attended.

They said they came away maintaining their buy rating on the stock with a bullish share price target, which we’ll get to shortly.

They added:

The R&D Day reiterated Mesoblast’s expectations to double its current revenue run-rate of About US$100m for RYONCIL in paediatric aGVHD in the medium term. Ongoing revenue growth efforts for the paediatric population include on-site access to RYONCIL, and progressing the treatment into 1L therapy. We garnered more colour on trial design for RYONCIL’s expansion into the adult population…its likely current off-label use in adults suggests to us that uptake will likely be rapid (about US $600m peak sales), should the trial read positive in less than 18 months.

Canaccord said they still had questions about another Mesoblast compound, Revascor, around its regulatory and commercial strategy in heart failure, “mainly related to guiding physicians to understand which patients may benefit (and how the FDA will view this)”.

Further down the track, Canaccord said, Mesoblast was also targeting a chronic lower back pain treatment, with clinical trial results and potential approval 12 and 24 months away, respectively.

Canaccord has a price target of $3.23 on Mesoblast shares, which would be a return of 44.2% if achieved.

More good news

The broker’s research report was issued before this week’s news that Mesoblast had acquired chimeric antigen receptor (CAR) platform technology, which would enable the manufacture of precision-enhanced cell products.

Mesoblast said it “plans to incorporate the engineered CARs to further boost effectiveness of Mesoblast’s products, with the goal of enhancing the target specificity and augmenting inherent properties of immunomodulation and tissue regeneration”.

The company added:

Mesoblast’s mesenchymal lineage stromal cell (MSC) technology platforms, including the first and only FDA-approved MSC product in the U.S., are designed for the treatment of tissue-specific inflammatory diseases due to their inherent homing capabilities and immunomodulatory properties. The aim of genetically engineering CAR constructs into MSCs is to substantially enhance targeted homing to inflamed tissue resulting in greater potency.

Mesoblast is currently valued at $2.8 billion.

The post Down almost 20% this year, how high could Mesoblast shares go? appeared first on The Motley Fool Australia.

More reading

• Why are Mesoblast shares jumping 8% today?
• Why Evolution Mining, Mesoblast, Nufarm, and Virgin Australia shares are storming higher today
• Why Amaero, Mesoblast, Telix, and Tivan shares are charging higher today
• Why Challenger, Lotus Resources, Mesoblast, and Wildcat shares are falling today
• Mesoblast shares are back in the red on Tuesday. Here’s why

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are on the lookout for some investment ideas, then read on. That’s because Bell Potter has been busy picking out its best ideas for April from the smaller side of the market.

Listed below are two more ASX shares that the broker has just named as best buys for the month ahead. Here’s what it is saying about them:

Cogstate Ltd (ASX: CGS)

This digital cognitive assessment-focused healthcare technology company could be an ASX share to buy according to Bell Potter.

It highlights that the company has a significant contracted revenue backlog, which should be supportive of growth in the near term. The broker commented:

Cogstate is a healthcare technology company specialising in digital cognitive assessments, primarily for biopharma clinical trials across central nervous system indications including Alzheimer’s disease, rare diseases, and broader CNS conditions. Founded in 1999 and ASX-listed since 2004, the company’s core offerings span digital assessments for trial endpoints, rater training and certification, and central monitoring solutions.

CGS has worked with over 160 biopharma customers and is currently active across more than 130 clinical trials. The business model is underpinned by a contracted revenue backlog — currently $92.3m — though revenue recognition can be lumpy given its dependence on trial size, phase, and duration.

Praemium Ltd (ASX: PPS)

Another ASX share that has been named as a best buy in April by the broker is investment platform provider Praemium.

Bell Potter highlights that the company’s shares are attractively priced at around 16x forward earnings and suspects that a re-rating could take place if it continues to grow its market share and funds under administration (FUA).

Commenting on the company, the broker said:

Praemium Ltd was formed in 2001 as a financial technology company that operates an investment platform offering alongside a branded online portfolio administration service, supporting financial intermediaries and individual investors in their managing wealth. The integrated technology simplifies portfolio management end-to-end and delivers a complete value proposition. Today, PPS manages +$60bn in custodial and non-custodial FUA.

While Praemium has demonstrated commercial momentum, strong growth capacity, and a leading technology offering, its valuation continues to lag key peers. This stock looks very attractive at a 12MF PE of ~15.9x, and we expect the market to catch on as the company executes on further market share gains and FUA growth.

The post Bell Potter names more of the best ASX shares to buy in April appeared first on The Motley Fool Australia.

More reading

• Are Cogsgate shares a buy, hold or sell after rocketing 12% higher yesterday?
• This ASX healthcare stock is up 70% in a year and climbing again today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cogstate and Praemium. The Motley Fool Australia has positions in and has recommended Cogstate. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Insignia Financial Ltd (ASX: IFL) share price is in focus today as the company announced court approval for its acquisition by Daintree BidCo Pty Ltd, enabling shareholders to receive $4.80 per share cash if all proceeds as planned.

What did Insignia Financial report?

• The Federal Court approved Daintree BidCo’s takeover of Insignia Financial by scheme of arrangement.
• Shareholders to receive a total of $4.80 cash per Insignia Financial share, subject to implementation.
• The scheme will become legally effective upon lodgement of court orders with ASIC, expected 17 April 2026.
• Shares will be suspended from trading on the ASX after close of trading, 17 April 2026.
• Implementation of the scheme expected 28 April 2026 for those on the register at 5:00pm 21 April 2026.

What else do investors need to know?

The scheme is being facilitated by Daintree BidCo Pty Ltd, an entity established by CC Capital Partners. Once the court orders are lodged with ASIC, the scheme will become effective and Insignia Financial shares will be suspended from the ASX.

The proposed acquisition will result in eligible shareholders being paid a cash consideration of $4.80 per share. The current timetable is still indicative, and investors should be aware that dates and times may change if required.

What’s next for Insignia Financial?

Looking ahead, if all regulatory processes complete as anticipated, the scheme will be implemented on 28 April 2026. At that point, shareholders on the register as of the record date will receive their cash payment.

Insignia Financial will keep investors informed should any further changes arise regarding the timing or details of the transaction.

Insignia Financial share price snapshot

Over the past 12 months, Insignia Financial shares have risen 33%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 15% over the same period.

View Original Announcement

The post Court approves Insignia Financial scheme: $4.80 per share for holders appeared first on The Motley Fool Australia.

More reading

• Whitehaven Coal announces US$900m notes issue and debt refinancing
• Viva Energy share price halted pending update on Geelong Refinery fire
• AMP posts Q1 2026 results, launches $150m buyback
• Netwealth Group lifts FUA to $125.8B with strong quarterly flows
• PLS Group prices US$600m in senior notes for growth and refinancing

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on track to record a decline. At the time of writing, the benchmark index is down 0.25% to 8,957.6 points.

Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping:

29Metals Ltd (ASX: 29M)

The 29Metals share price is down 32% to 25.2 cents. Investors have been selling this copper producer’s shares following the release of an update on its progress to reestablish mining at the Xantho Extended orebody at the Golden Grove operation in Western Australia. It advised that based on a new assessment, additional works to further reduce the risk of future potential production interruptions will be needed prior to recommencement of mining. And while there is no change to its copper production guidance for FY 2026, it has downgraded its guidance for zinc, gold, and silver materially.

DGL Group Ltd (ASX: DGL)

The DGL Group share price is down 25% to 40 cents. This has been driven by the release of the chemicals logistics and services supplier’s half-year update. DGL Group reported a 5.8% decline in sales revenue to $225 million, a 5% decline in underlying EBITDA to $24.7 million, and a statutory loss after tax of $12.8 million. It notes that its revenue was impacted by ongoing scarcity in used lead acid batteries due to illegal exports.

Fletcher Building Ltd (ASX: FBU)

The Fletcher Building share price is down 1% to $2.44. This morning, the building products company released a quarterly sales update and revealed improvements in volumes. Fletcher Building’s CEO, Andrew Reding, said: “Quarterly volumes for the March quarter continued to show early signs of improvement across the portfolio, with the important caveat that this quarter largely preceded the current geopolitical escalation.” One negative was the company warning that the “overall impact of the Middle East crisis on the Group’s financial performance, including for the FY26 year, cannot be ascertained with certainty at this time.”

Newmont Corporation (ASX: NEM)

The Newmont share price is down 5% to $156.82. This is despite there being no news out of the gold miner today. However, it is worth noting that most ASX gold stocks are under pressure today. This has led to S&P/ASX All Ordinaries Gold index falling 2.15% this afternoon.

The post Why 29Metals, DGL, Fletcher Building, and Newmont shares are falling today appeared first on The Motley Fool Australia.

More reading

• Fletcher Building posts positive Q3 volumes amid new global risks
• 5 things to watch on the ASX 200 on Thursday
• 5 things to watch on the ASX 200 on Wednesday
• 5 things to watch on the ASX 200 on Monday
• 5 things to watch on the ASX 200 on Friday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.